H2N2 live attenuated influenza vaccine (NIAID)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH2N2 live attenuated influenza vaccine (NIAID)

Drug Alias NameH2N2减毒流感活疫苗-NIAID/MedImmune

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza in Birds

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Medimmune Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedimmune Llc National Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsN/A

Inactive IndicationsInfluenza in Birds

Other Information

ATC CodeN/A